IsoRay, Inc. States Its Policy Not to Comment on Unusual Market Activity

RICHLAND, Wash., Feb. 27, 2013 /PRNewswire/ -- IsoRay, Inc. (NYSE MKT: ISR) ("IsoRay" or the "Company"), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, released the following statement today.

In view of the unusual market activity in IsoRay's common stock on February 26 and 27, 2013, the New York Stock Exchange has contacted the Company in accordance with its usual practice. IsoRay stated that its policy is not to comment on unusual market activity.

About IsoRay
IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc. is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body.  Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com. Join us on http://www.facebook.com/#/Isoray.   Follow us on https://twitter.com/#!/Isoray.

Contact:
Worldwide Financial
(954) 360-9998
info@wwfinancial.com

SOURCE IsoRay, Inc.



RELATED LINKS
http://www.isoray.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.